Setting traps for NKG2A gives NK cell immunotherapy a fighting chance

This study provides proof of concept for a new immunotherapeutic approach using NKG2Anull NK cells.

Source: Journal of Clinical Investigation - April 16, 2019 Category: Biomedical Science Authors: Frank Cichocki, Jeffrey S. Miller Source Type: research